Our Stroke portfolio delivers life-saving interventional solutions for patients with ischemic stroke for the best chance of a full recovery.
Our Vascular portfolio is transforming thrombectomy care for people suffering from devastating vascular diseases, including venous thromboembolism and acute limb ischemia.
We are developing the Telos robotic platform* to expand access to lifesaving care through purposeful design and innovation.
*Currently in development. Not approved for use or available for sale.
Imperative Care is addressing gaps across the entire patient journey to elevate care for patients suffering from stroke and other devastating vascular diseases.
Back to News
August 24, 2022
Imperative Care Announces Positive New Data Underscoring the Safety and Efficacy of the Zoom Stroke Solution to Treat Distal Occlusions in Ischemic Stroke Patients
July 26, 2022
Imperative Care Announces Positive Real-World Data Showing that the Zoom Stroke Solution Achieved Superior Procedure Outcomes with Lower Cost in Ischemic Stroke Patients
July 18, 2022
Imperative Care Appoints Henrietta Fore and Stacy Enxing Seng to Board of Directors
May 25, 2022
Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies
February 14, 2022
Imperative Care Announces the Launch of Its Zoom POD for Stroke Treatment, the First and Only Filter to Capture Clot in the Sterile Field
Media Contact
Rigo Magana
Corporate Communications
rmagana@imperativecare.com
Investor Contact
Phil Nalbone
VP of Corporate Development and Investor Relations
pnalbone@imperativecare.com
Contact us
